Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-27 Purchase |
2025-01-31 5:06 pm |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
12,400 | $0.7975 | $9,889 | 47,369 (Indirect Direct) |
View |
| 2025-01-27 Purchase |
2025-01-29 5:05 pm |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
87,200 | $0.7975 | $69,542 | 107,200 (Indirect) |
View |
| 2025-01-27 Purchase |
2025-01-29 4:24 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
124,500 | $0.7975 | $99,289 | 265,720 (Indirect Direct) |
View |
| 2025-01-27 Purchase |
2025-01-29 4:20 pm |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
43,500 | $0.7975 | $34,691 | 72,559 (Indirect Direct) |
View |
| 2024-02-07 Purchase |
2024-02-08 4:30 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
21,000 | $2.4536 | $51,526 | 139,702 (Indirect Direct) |
View |
| 2024-02-06 Purchase |
2024-02-07 4:22 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
20,000 | $2.5252 | $50,504 | 118,702 (Indirect Direct) |
View |
| 2024-01-31 Purchase |
2024-02-01 6:32 pm |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
4,000 | $2.3813 | $9,525 | 27,478 (Direct) |
View |
| 2024-01-30 Purchase |
2024-01-31 4:37 pm |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
10,000 | $2.7 | $27,000 | 20,000 (Indirect) |
View |
| 2024-01-30 Purchase |
2024-01-31 4:34 pm |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
8,000 | $2.693 | $21,544 | 34,969 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Exercise |
2025-04-11 5:22 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
14,482 | $0 | 82,227 (Direct) |
View |
| 2025-04-01 Tax Withholding |
2025-04-11 5:22 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
4,814 | $0.412 | 82,227 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-11 5:20 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
14,482 | $0 | 34,674 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-11 5:17 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
15,059 | $0 | 40,294 (Direct) |
View |
| 2025-04-01 Tax Withholding |
2025-04-11 5:17 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
3,311 | $0.412 | 40,294 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-11 5:16 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
17,272 | $0 | 277,647 (Direct) |
View |
| 2025-04-01 Tax Withholding |
2025-04-11 5:16 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
5,345 | $0.412 | 277,647 (Direct) |
View |
| 2025-01-29 Option Award(A) |
2025-02-18 5:59 pm |
2025-01-29 2030-01-29 |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
18,600 | $0 | 65,969 (Indirect) |
View |
| 2025-01-29 Option Award(A) |
2025-02-18 5:57 pm |
2025-01-29 2030-01-29 |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
186,750 | $0 | 452,470 (Direct) |
View |
| 2025-01-29 Option Award(A) |
2025-02-18 5:54 pm |
2025-01-29 2030-01-29 |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
65,250 | $0 | 137,809 (Indirect) |
View |
| 2025-01-29 Option Award(A) |
2025-02-18 5:53 pm |
2025-01-29 2030-01-29 |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
130,800 | $0 | 238,000 (Indirect) |
View |
| 2024-09-03 Option Award |
2024-09-18 4:51 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
31,206 | $0 | 31,206 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-18 4:50 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
31,206 | $0 | 31,206 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-18 4:48 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Neal James R Director |
31,206 | $0 | 31,206 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-18 4:47 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director |
31,206 | $0 | 31,206 (Direct) |
View |
| 2024-04-05 Exercise |
2024-08-02 5:34 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
2,319 | $0 | 135,945 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-08-02 5:34 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
225 | $1.71 | 135,945 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-02 5:34 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
6,466 | $0 | 135,945 (Direct) |
View |
| 2024-04-05 Tax Withholding |
2024-08-02 5:34 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
368 | $2.79 | 135,945 (Direct) |
View |
| 2024-04-05 Exercise |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
2,319 | $0 | 120,438 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
282 | $1.71 | 120,438 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,154 | $0 | 120,438 (Direct) |
View |
| 2024-04-05 Tax Withholding |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
518 | $2.79 | 120,438 (Direct) |
View |
| 2024-04-05 Exercise |
2024-08-02 5:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
2,319 | $0 | 124,985 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-08-02 5:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
271 | $1.71 | 124,985 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-02 5:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
5,426 | $0 | 124,985 (Direct) |
View |
| 2024-04-05 Tax Withholding |
2024-08-02 5:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
539 | $2.79 | 124,985 (Direct) |
View |
| 2024-04-05 Exercise |
2024-08-02 5:12 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
2,319 | $0 | 116,118 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-08-02 5:12 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
220 | $1.71 | 116,118 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-02 5:12 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
5,426 | $0 | 116,118 (Direct) |
View |
| 2024-04-05 Tax Withholding |
2024-08-02 5:12 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
368 | $2.79 | 116,118 (Direct) |
View |
| 2024-04-05 Exercise |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
2,319 | $0 | 237,395 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
282 | $1.71 | 237,395 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
6,466 | $0 | 237,395 (Direct) |
View |
| 2024-04-05 Tax Withholding |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
518 | $2.79 | 237,395 (Direct) |
View |
| 2024-07-16 Option Award |
2024-07-18 4:46 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | SKIBSTED RUSSELL Chief Financial Officer |
28,000 | $0 | 28,000 (Direct) |
View |
| 2024-01-01 Exercise |
2024-04-12 5:01 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
1,675 | $0 | 160,192 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-04-12 5:01 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
518 | $2.79 | 160,192 (Direct) |
View |
| 2024-01-01 Exercise |
2024-04-12 4:57 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
1,675 | $0 | 30,157 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-04-12 4:57 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
518 | $2.79 | 30,157 (Direct) |
View |
| 2024-01-01 Exercise |
2024-04-12 4:55 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
1,675 | $0 | 48,746 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-04-12 4:55 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
539 | $2.79 | 48,746 (Direct) |
View |
| 2024-01-01 Exercise |
2024-04-12 4:52 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
1,675 | $0 | 50,265 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-04-12 4:52 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
368 | $2.79 | 50,265 (Direct) |
View |
| 2024-01-01 Exercise |
2024-04-12 4:50 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
1,675 | $0 | 39,900 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-04-12 4:50 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
368 | $2.79 | 39,900 (Direct) |
View |
| 2023-11-21 Other |
2023-11-28 4:13 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
55,267 | $0 | 594,619 (Indirect) |
View |
| 2023-10-12 Option Award(A) |
2023-10-23 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
6,000 | $0.3 | 594,619 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 6:07 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
14,771 | $0.34 | 369,208 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 6:04 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
100,000 | $0.25 | 200,000 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 6:01 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
5,000 | $0.32 | 469,535 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 5:58 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
15,000 | $0.33 | 99,250 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 5:56 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
6,000 | $0.3 | 595,619 (Direct) |
View |